Angiotech closes AMI acquisition
This article was originally published in The Gray Sheet
Executive Summary
The specialty pharmaceutical company announces March 23 the close of its acquisition of American Medical Instruments for $785 mil. When the acquisition was first announced Feb. 1, Angiotech highlighted opportunities to apply its medical coatings to a variety of AMI products, including ophthalmic blades and biopsy needles (1"The Gray Sheet" Feb. 20, 2006, p. 14). With the acquisition, Angiotech also gains control of AMI's established manufacturing and sales operations...
You may also be interested in...
With AMI Buy, Angiotech Looks To Become Less Reliant On Partnerships
Angiotech Pharmaceuticals' $785 mil. acquisition of American Medical Instruments Holdings will allow the firm to diversify its revenue stream and retain more control over its combination product business
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.